MetLife with ticker code (MET) now have 15 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 83 and 74 calculating the mean target price we have 77.53. Given that the stocks previous close was at 66.47 this now indicates there is a potential upside of 16.6%. There is a 50 day moving average of 64.01 and the 200 day MA is 65.37. The market capitalisation for the company is $52,970m. Company Website: https://www.metlife.com
The potential market cap would be $61,783m based on the market concensus.
MetLife, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife was founded in 1863 and is headquartered in New York, New York.
